首页> 外文OA文献 >Fevers post infusion of T-cell replete hla mismatched haploidentical hematopoietic stem cells with post-transplant cyclophosphamide: risk factors and impact on transplant outcomes

【2h】

Fevers post infusion of T-cell replete hla mismatched haploidentical hematopoietic stem cells with post-transplant cyclophosphamide: risk factors and impact on transplant outcomes

机译：发烧后输注T细胞催眠术HLA失配造血干细胞与移植后的环磷酰胺：危险因素和对移植结果的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Melhem M. Solh; Elizabeth Dickhaus; Scott R. Solomon; Lawrence E. Morris; Xu Zhang; H. Kent Holland; Asad Bashey;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Fevers post infusion of T-cell replete hla mismatched haploidentical hematopoietic stem cells with post-transplant cyclophosphamide: risk factors and impact on transplant outcomes [J] . Solh Melhem M., Dickhaus Elizabeth, Solomon Scott R., Bone marrow transplantation . 2019,第11期

机译：发烧后输注T细胞催眠术HLA失配造血干细胞与移植后的环磷酰胺：危险因素和对移植结果的影响
2. Immune reconstitution after T-cell replete HLA haploidentical?hematopoietic stem cell?transplantation using high-dose post-transplant cyclophosphamide [J] . Yoshinobu Maeda Journal of clinical and experimental hematopathology : . 2021,第1期

机译：T-Cell Repete HLA Haploidentical？造血干细胞的免疫重建α〜使用高剂量后移植后环磷酰胺移植
3. Survival after T-Cell Replete Haploidentical Related Donor Hematopoietic Cell Transplantation (Haplo-HCT) Using Post-Transplant Cyclophosphamide (PT-CY) Compared with HLA-Matched Related Donor (MRD) Transplant for Lymphomas [J] . Karmali Reem, Ghosh Nilanjan, Rocha Vanderson G., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：与移植后HLA匹配的相关供体（MRD）相比，使用移植后环磷酰胺（PT-CY）进行T细胞大量单倍体相关供体造血细胞移植（Haplo-HCT）的存活率
4. HIGH RISK OF GRAFT FAILURE IN PATIENTS WITH ANTI-HLA ANTIBODIES UNDERGOING HAPLOIDENTICAL STEM CELL TRANSPLANTATION [C] . Stefan O. Ciurea, Marcos de Lima, Pedro Cano, Clinical Histocompatibility Workshop. . 2009

机译：抗HLA抗体患者接枝衰竭的高风险，抗HLA抗体患者进行了寄生干细胞移植
5. Pre-Transplant Risk Factors Associated With Worse Outcomes in Adolescents and Young Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [D] . Friend, Brian. 2018

机译：与经历同种异体造血干细胞移植的青少年和青少年较差的预移植危险因素
6. Cytomegalovirus viremia disease and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide [O] . Scott R. Goldsmith, Michael Slade, John F. DiPersio, 2016

机译：巨细胞病毒血症疾病及其对T细胞充足性外周血单向造血细胞移植后T-环磷酰胺移植的复发的影响
7. Survival after T-Cell Replete Haploidentical Related Donor Hematopoietic Cell Transplantation (Haplo-HCT) Using Post-Transplant Cyclophosphamide (PT-CY) Compared with HLA-Matched Related Donor (MRD) Transplant for Lymphomas [O] . Reem Karmali, Nilanjan Ghosh, Vanderson G. Rocha, 2016

机译：与HLA匹配的相关供体（MRD）移植进行淋巴瘤，使用后移植后环磷酰胺（PT-CY）进行T-Cell Replete Haploidentical相关供体造血细胞移植（HAPLO-HCT）。
8. Development of Augmented Leukemia/Lymphoma-Specific T-Cell Immunotherapy for Deployment with Haploidentical Hematopoietic Progenitor-Cell Transplant. [R] . Cooper, L. 2010

机译：发展增强白血病/淋巴瘤特异性T细胞免疫治疗部署与单倍体相合的造血祖细胞移植。

Fevers post infusion of T-cell replete hla mismatched haploidentical hematopoietic stem cells with post-transplant cyclophosphamide: risk factors and impact on transplant outcomes

著录项

引文网络

相似文献

相关主题

期刊订阅